These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32452322)

  • 21. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 22. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
    Dasgupta S; Ghosh SK; Ray S; Mazumder B
    Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of solid lipid nanoparticles as photoprotective agents in cosmetics.
    Jose J; Netto G
    J Cosmet Dermatol; 2019 Feb; 18(1):315-321. PubMed ID: 29441672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.
    Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
    Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
    Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation.
    Al-Amin M; Cao J; Naeem M; Banna H; Kim MS; Jung Y; Chung HY; Moon HR; Yoo JW
    Drug Des Devel Ther; 2016; 10():3947-3957. PubMed ID: 27980392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances and development in epidermal and dermal drug deposition enhancement technology.
    Iqbal B; Ali J; Baboota S
    Int J Dermatol; 2018 Jun; 57(6):646-660. PubMed ID: 29430629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Drug Delivery System for Dermal Uptake of Etofenamate: Semisolid SLN Dispersion.
    Badilli U; Sengel-Turk CT; Amasya G; Tarimci N
    Curr Drug Deliv; 2017; 14(3):386-393. PubMed ID: 27501715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructured lipid carriers: A potential use for skin drug delivery systems.
    Czajkowska-Kośnik A; Szekalska M; Winnicka K
    Pharmacol Rep; 2019 Feb; 71(1):156-166. PubMed ID: 30550996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current view on nanosized solid lipid carriers for drug delivery to the skin.
    Kristl J; Teskac K; Grabnar PA
    J Biomed Nanotechnol; 2010 Oct; 6(5):529-42. PubMed ID: 21329046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid lipid nanoparticles: a review on recent perspectives and patents.
    Paliwal R; Paliwal SR; Kenwat R; Kurmi BD; Sahu MK
    Expert Opin Ther Pat; 2020 Mar; 30(3):179-194. PubMed ID: 32003260
    [No Abstract]   [Full Text] [Related]  

  • 34. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
    Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
    Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
    Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.